dc.contributorHosp. for Oral Health Care Sciences
dc.contributorUniversidade Estadual de Campinas (UNICAMP)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversity of London
dc.date.accessioned2014-05-27T11:18:13Z
dc.date.available2014-05-27T11:18:13Z
dc.date.created2014-05-27T11:18:13Z
dc.date.issued1997-05-01
dc.identifierOral Diseases, v. 3, n. SUPPL. 1, 1997.
dc.identifier1354-523X
dc.identifierhttp://hdl.handle.net/11449/65096
dc.identifier10.1111/j.1601-0825.1997.tb00361.x
dc.identifier2-s2.0-0030940888
dc.description.abstractThe deep mycoses are uncommon infections, usually acquired from the inhalation or ingestion of fungal spores, sometimes from the soil in areas of endemicity, such as in the Americas and south-east Asia, or from decaying vegetable matter. They are also seen in immunocompromised persons and, increasingly, in HIV-infected persons. Respiratory involvement is frequent, with granuloma formation, and mucocutaneous involvement may be seen. Oral lesions of the deep mycoses are typically chronic but non-specific, though nodular or ulcerative appearances are common. Person-to-person transmission is rare. In HIV disease, the most common orofacial involvement of deep mycoses has been in histoplasmosis, cryptococcosis, aspergillosis and zygomycosis. Diagnosis is usually confirmed by lesional biopsy although culture may also be valuable. Treatment is with amphotericin or an azole.
dc.languageeng
dc.relationOral Diseases
dc.relation2.310
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectHIV
dc.subjectMycoses
dc.subjectOral
dc.subjectamphotericin b
dc.subjectcotrimazine
dc.subjectfluconazole
dc.subjectflucytosine
dc.subjectitraconazole
dc.subjectketoconazole
dc.subjectmiconazole
dc.subjectrifampicin
dc.subjectsulfamethoxypyridazine
dc.subjectaspergillosis
dc.subjectbiopsy
dc.subjectblastomycosis
dc.subjectcoccidioidomycosis
dc.subjectconference paper
dc.subjectcryptococcosis
dc.subjectfungus culture
dc.subjecthistoplasmosis
dc.subjecthuman
dc.subjecthuman immunodeficiency virus infection
dc.subjectimmune deficiency
dc.subjectintravenous drug administration
dc.subjectlung granuloma
dc.subjectmucormycosis
dc.subjectmycosis
dc.subjectoral drug administration
dc.subjectpriority journal
dc.subjectserodiagnosis
dc.subjectside effect
dc.subjectsouth american blastomycosis
dc.subjectAcquired Immunodeficiency Syndrome
dc.subjectAdult
dc.subjectAIDS-Related Opportunistic Infections
dc.subjectAmphotericin B
dc.subjectAspergillosis
dc.subjectAzoles
dc.subjectCryptococcosis
dc.subjectFemale
dc.subjectHistoplasmosis
dc.subjectHIV Infections
dc.subjectHumans
dc.subjectLung Diseases, Fungal
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectMouth Diseases
dc.subjectMucormycosis
dc.subjectSinusitis
dc.titleThe deep mycoses in HIV infection
dc.typeActas de congresos


Este ítem pertenece a la siguiente institución